Belgium vs Indonesia: Previously treated cases tested for RR-/MDR-TB
Belgium
83.0%
in 2024
Indonesia
83.0%
in 2024
Belgium rank
104th
Indonesia rank
104th
Previously treated cases tested for RR-/MDR-TB over time
- Belgium
- Indonesia
How they compare
Belgium currently reports 83.0% against 83.0% in Indonesia, a difference of 0.0%.
The two have swapped places 3 times across 15 shared years of data; in 2010 it was Belgium ahead.
Belgium ranks 104th and Indonesia ranks 104th of 180 countries.
Across the 2 decades both report, Belgium averaged higher in 1 and Indonesia in 1.
Head to head by decade
| Decade | Belgium | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 70.1% | 63.3% | 6.8% | Belgium |
| 2020s | 79.4% | 84.4% | 5.0% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Belgium or Indonesia?
- Belgium, at 83.0% against 83.0% in Indonesia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Belgium and Indonesia?
- 0.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Indonesia?
- 15 years are reported by both, from 2010 to 2024.
- How do Belgium and Indonesia rank globally for previously treated cases tested for rr-/mdr-tb?
- Belgium ranks 104th and Indonesia ranks 104th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.